136 related articles for article (PubMed ID: 27413481)
1. The Role of Spinal Dopaminergic Transmission in the Analgesic Effect of Nefopam on Rat Inflammatory Pain.
Kim do Y; Chae JW; Lim CH; Heo BH; Park KS; Lee HG; Choi JI; Yoon MH; Kim WM
Korean J Pain; 2016 Jul; 29(3):164-71. PubMed ID: 27413481
[TBL] [Abstract][Full Text] [Related]
2. Spinal noradrenergic modulation and the role of the alpha-2 receptor in the antinociceptive effect of intrathecal nefopam in the formalin test.
Jeong SH; Heo BH; Park SH; Kim WM; Lee HG; Yoon MH; Choi JI
Korean J Pain; 2014 Jan; 27(1):23-9. PubMed ID: 24478897
[TBL] [Abstract][Full Text] [Related]
3. Antinociceptive effects of nefopam modulating serotonergic, adrenergic, and glutamatergic neurotransmission in the spinal cord.
Chae JW; Kang DH; Li Y; Kim SH; Lee HG; Choi JI; Yoon MH; Kim WM
Neurosci Lett; 2020 Jul; 731():135057. PubMed ID: 32450186
[TBL] [Abstract][Full Text] [Related]
4. Antinociceptive effects of nefopam activating descending serotonergic modulation via 5-HT2 receptors in the nucleus raphe magnus.
Li Y; Kim WM; Lee YJ; Kang DH; Lee HG; Choi JI; Yoon MH
Eur J Pain; 2024 Feb; 28(2):252-262. PubMed ID: 37615256
[TBL] [Abstract][Full Text] [Related]
5. Antinociceptive effect of intrathecal nefopam and interaction with morphine in formalin-induced pain of rats.
Cho SY; Park AR; Yoon MH; Lee HG; Kim WM; Choi JI
Korean J Pain; 2013 Jan; 26(1):14-20. PubMed ID: 23342202
[TBL] [Abstract][Full Text] [Related]
6. Intrathecal nefopam-induced antinociception through activation of descending serotonergic projections involving spinal 5-HT7 but not 5-HT3 receptors.
Lee HG; Kim WM; Kim JM; Bae HB; Choi JI
Neurosci Lett; 2015 Feb; 587():120-5. PubMed ID: 25534502
[TBL] [Abstract][Full Text] [Related]
7. The effects of intrathecally administered FK480, a cholecystokinin-A receptor antagonist, and YM022, a cholecystokinin-B receptor antagonist, on the formalin test in the rat.
Yamamoto T; Nozaki-Taguchi N
Anesth Analg; 1996 Jul; 83(1):107-13. PubMed ID: 8659718
[TBL] [Abstract][Full Text] [Related]
8. Role of the 5-HT(7) receptor in the effects of intrathecal nefopam in neuropathic pain in rats.
Dam LJ; Hai L; Ha YM
Neurosci Lett; 2014 Apr; 566():50-4. PubMed ID: 24561091
[TBL] [Abstract][Full Text] [Related]
9. Analgesic effect of intrathecally administered nociceptin, an opioid receptor-like1 receptor agonist, in the rat formalin test.
Yamamoto T; Nozaki-Taguchi N; Kimura S
Neuroscience; 1997 Nov; 81(1):249-54. PubMed ID: 9300417
[TBL] [Abstract][Full Text] [Related]
10. Role of catecholamines and serotonin receptor subtypes in nefopam-induced antinociception.
Girard P; Coppé MC; Verniers D; Pansart Y; Gillardin JM
Pharmacol Res; 2006 Sep; 54(3):195-202. PubMed ID: 16750379
[TBL] [Abstract][Full Text] [Related]
11. Nefopam and ketoprofen synergy in rodent models of antinociception.
Girard P; Verniers D; Coppé MC; Pansart Y; Gillardin JM
Eur J Pharmacol; 2008 Apr; 584(2-3):263-71. PubMed ID: 18316069
[TBL] [Abstract][Full Text] [Related]
12. The analgesic activity of intrathecal tianeptine, an atypical antidepressant, in a rat model of inflammatory pain.
Kim WM; Lee SH; Jeong HJ; Lee HG; Choi JI; Yoon MH
Anesth Analg; 2012 Mar; 114(3):683-9. PubMed ID: 22253265
[TBL] [Abstract][Full Text] [Related]
13. Involvement of dopamine in the mechanism of action of FR64822, a novel non-opioid antinociceptive compound.
Ohkubo Y; Nomura K; Yamaguchi I
Eur J Pharmacol; 1991 Nov; 204(2):121-5. PubMed ID: 1839620
[TBL] [Abstract][Full Text] [Related]
14. Evidence of the involvement of dopamine in the analgesic effect of nefopam.
Esposito E; Romandini S; Merlo-Pich E; Mennini T; Samanin R
Eur J Pharmacol; 1986 Sep; 128(3):157-64. PubMed ID: 3098570
[TBL] [Abstract][Full Text] [Related]
15. Antinociceptive effect of prostatic acid phosphatase in a rat model of cancer-induced bone pain.
Chen L; Zhu L; Wang K; Wang W; Mei XP; Liu T; Zhang FX; Wang W; Chen T; Li YQ
Pain Physician; 2013; 16(6):533-46. PubMed ID: 24284839
[TBL] [Abstract][Full Text] [Related]
16. Effects of the selective sigma-1 receptor antagonist S1RA on formalin-induced pain behavior and neurotransmitter release in the spinal cord in rats.
Vidal-Torres A; Fernández-Pastor B; Carceller A; Vela JM; Merlos M; Zamanillo D
J Neurochem; 2014 May; 129(3):484-94. PubMed ID: 24384038
[TBL] [Abstract][Full Text] [Related]
17. Spinal antinociceptive action of amiloride and its interaction with tizanidine in the rat formalin test.
Ouyang H; Wang P; Huang W; Li Q; Nie B; Zeng W
Pain Res Manag; 2015; 20(6):321-6. PubMed ID: 26357686
[TBL] [Abstract][Full Text] [Related]
18. Analgesic effect of intrathecally administered orexin-A in the rat formalin test and in the rat hot plate test.
Yamamoto T; Nozaki-Taguchi N; Chiba T
Br J Pharmacol; 2002 Sep; 137(2):170-6. PubMed ID: 12208773
[TBL] [Abstract][Full Text] [Related]
19. The antihyperalgesic effects of intrathecal bupropion, a dopamine and noradrenaline reuptake inhibitor, in a rat model of neuropathic pain.
Hoshino H; Obata H; Nakajima K; Mieda R; Saito S
Anesth Analg; 2015 Feb; 120(2):460-6. PubMed ID: 25427287
[TBL] [Abstract][Full Text] [Related]
20. Antinociceptive effects of (+/-)-, (+)- and (-)-nefopam in mice.
Fasmer OB; Berge OG; Jørgensen HA; Hole K
J Pharm Pharmacol; 1987 Jul; 39(7):508-11. PubMed ID: 2886617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
